Skip to main content
. 2022 Jun 9;22:634. doi: 10.1186/s12885-022-09698-8

Table 1.

Summary of the exclusion reasons for all three eligibility evaluation steps

Reason for exclusion Number
Abstracts/Comments/Letters 60
Metastatic focus 17
Dubious article/Language/Not found 45
Different method/Goal 162
No performance data 54
Too specific subtype of BC 11
Unclear stage data 33
 > 4,5% stage IV samples 31
Review/Meta-analysis 86
Prognostic 68
Not related to BC 3
Exosomal miRNAs 23
Therapeutic 47
Not biomarker focused 26
Total excluded publications 666